25/04/2019 16:21:57

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DPLO, CVS, UMC and AAPL

NEW YORK, April 25, 2019 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.        

Diplomat Pharmacy, Inc. (NYSE: DPLO)

Class Period: February 26, 2018 to February 21, 2019

Lead Plaintiff Deadline: April 25, 2019

The lawsuit alleges that Diplomat Pharmacy, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Diplomat had downplayed its success in integrating and growing its PBM business, which included LDI Integrated and National Pharmaceutical, two companies Diplomat had acquired in late 2017; (2) consequently, Diplomat would need to record a non-cash impairment charge upwards of approximately $630 million relating to its PBM business and these 2017 acquisitions; (3) due to the foregoing, Diplomat would withdraw its preliminary 2019 full-year outlook issued less than seven weeks prior; and (4) as a result, defendants’ statements about Diplomat’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Get additional information about the DPLO lawsuit: https://www.kleinstocklaw.com/pslra-1/diplomat-pharmacy-inc-loss-submission-form?wire=3

CVS Health Corporation (NYSE: CVS)

Class Period: May 21, 2015 to February 20, 2019

Lead Plaintiff Deadline: April 26, 2019

The complaint alleges that during the class period CVS Health Corporation made materially false and/or misleading statements and/or failed to disclose that: (i) CVS Health’s financial condition and expected earnings were deteriorating as a result of rising costs and poor results associated with the Omnicare Acquisition; and (ii) as a result, CVS Health’s public statements were materially false and misleading at all relevant times.

Get additional information about the CVS lawsuit: https://www.kleinstocklaw.com/pslra-1/cvs-health-corporation-loss-submission-form?wire=3

United Microelectronics Corporation (NYSE: UMC)

Class Period: October 28, 2015 to November 1, 2018

Lead Plaintiff Deadline: May 13, 2019

During the class period, United Microelectronics Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) UMC conspired with Fujian to steal trade secrets from Micron relating to its research and development of Dynamic Random-Access Memory ("DRAM"); (ii) UMC hired former Micron employees for the purpose of stealing such information from Micron; (iii) the foregoing conduct placed UMC and certain of its employees at an increased risk of criminal and regulatory investigation by the U.S. government; and (iv) as a result, UMC’s public statements were materially false and misleading at all relevant times.

Get additional information about the UMC lawsuit: https://www.kleinstocklaw.com/pslra-1/united-microelectronics-corporation-loss-submission-form?wire=3

Apple Inc. (NASDAQGS: AAPL)

Class Period: November 2, 2018 to January 2, 2019

Lead Plaintiff Deadline: June 17, 2019

The lawsuit alleges that throughout the class period, Apple Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) the U.S.-China trade war had negatively impacted demand for iPhones and Apple’s pricing power in greater China, one of Apple’s most important growth markets; (b) the rate at which Apple customers were replacing their batteries in older iPhones rather than purchasing new iPhones was negatively impacting Apple’s iPhone sales growth; (c) as a result of slowing demand, Apple had slashed production orders from suppliers for the new 2018 iPhone models and cut prices to reduce inventory; (d) unit sales for iPhone and other hardware was relevant to investors and the Company’s financial performance, and the decision to withhold such unit sales was designed to and would mask declines in unit sales of the Company’s flagship product; and (e) as a result of the foregoing, defendants lacked a reasonable basis in fact when issuing the Company’s revenue outlook for the first quarter 2019 and/or making the related statements concerning demand for its products, as Apple’s business metrics and financial prospects were not as strong as defendants had led the market to believe.

Get additional information about the AAPL lawsuit: https://www.kleinstocklaw.com/pslra-1/apple-inc-loss-submission-form-2?wire=3

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.

Empire State Building

350 Fifth Avenue

59th Floor

New York, NY 10118

jk@kleinstocklaw.com

Telephone: (212) 616-4899

Fax: (347) 558-9665

www.kleinstocklaw.com

Klein NEW logo black transparent.png

Related content
17 Sep - 
INVESTOR ACTION ALERT: The Schall Law Firm Announces th..
17 Sep - 
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL:..
16 Sep - 
CLASS ACTION UPDATE for CARB, TWOU, CVS and MDP: Levi &..
Related debate
21 Aug - 
I sin tid ønskede politikkeren en stram pengepolitik me..
21 Aug - 
Undskyld, men det er et billigt argument. Det der især ..
20 Aug - 
Hahaha 😂 point for god humor og et indlæg uden Trump-b..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
UPDATE - Yoko Ono and John Lennon Educational Tour Bus “Imagine A City With No Gun Violence!”
2
Translate Bio Announces Pricing of Public Offering of Common Stock
3
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SAExploration Holdings, Inc. - SAEX
4
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
5
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Pluralsight, Inc. - PS

Related stock quotes

Apple Inc 222.77 0.9% Stock price increasing
CVS Health Corporation 63.26 -0.3% Stock price decreasing
Diplomat Pharmacy Inc 5.520 -1.6% Stock price decreasing
United Microelectronics .. 2.170 0.0% Stock price unchanged

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
18 September 2019 23:38:12
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190829.2 - EUROWEB4 - 2019-09-19 00:38:12 - 2019-09-18 23:38:12 - 1000 - Website: OKAY